Clinical Trial Update: Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety of inhaled preprandial human insulin in adults with diabetes and asthma (terminated).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Diabetes Mellitus

Drugs mentioned

• Inhaled preprandial human insulin (insulin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: TERMINATED